Quantcast

Latest Chemokine Stories

2009-04-14 07:30:00

Trial to Evaluate Safety of CCL2-LPM for Inflammatory Kidney Disease SAN FRANCISCO, April 14 /PRNewswire/ -- Osprey Pharmaceuticals U.S.A., Inc.

2009-04-08 08:46:14

An inflammatory factor already linked to several diseases, including pulmonary disease, lung cancer, and arthritis, may also be responsible for the insulin resistance that comes with obesity, according to a new study published in the April issue of Cell Metabolism, a Cell Press publication.

2009-02-03 06:00:00

Therapeutic Approach Provides HIV-Resistant Immune Cells RICHMOND, Calif., Feb. 3 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc.

92365227d48105f53ed411c249b276f51
2009-01-30 09:38:58

If you've ever wondered why some allergic reactions progress quickly and may even become fatal, a new research report published in the February 2009 issue of the Journal of Leukocyte Biology provides an important part of the answer.

2009-01-05 14:54:00

San Diego-Based Carolus Therapeutics Focuses on Discovery and Development of Anti-Inflammatory Drugs Based on Collaborators' Findings at RWTH Aachen University in Germany SAN DIEGO, Jan.

5ee4b95a2b75a816a69d4d466caa0a3c1
2008-11-27 10:06:17

As the holidays arrive, a group of researchers has identified the precise mechanisms by which binge drinking contributes to clogs in arteries that lead to heart attack and stroke.

2008-10-28 18:00:28

WASHINGTON and RICHMOND, Calif., Oct. 28 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc.

2008-10-16 12:00:25

ChemoCentryx, a clinical-stage biopharmaceutical company, has initiated a Phase I clinical trial of CCX025, the company's fourth investigational new drug and second orally administered compound that inhibits the chemokine receptor known as CCR9.

2008-10-15 09:00:08

MOUNTAIN VIEW, Calif., Oct. 15 /PRNewswire/ -- ChemoCentryx, Inc., announced today that it has initiated a Phase I clinical trial of CCX025, the company's fourth investigational new drug and second orally administered compound that inhibits the chemokine receptor known as CCR9.

2008-09-16 15:00:38

U.S. medical scientists say they have created a synthetic form of a protein that is involved in certain types of cancer and immune system diseases. Researchers at the Medical College of Wisconsin-Milwaukee said they have applied for a patent on the protein, CXCL12, which is known as a chemokine.


Word of the Day
megalophonous
  • Having a loud voice; vociferous; clamorous.
  • Of grand or imposing sound.
The word 'megalophonous' comes from Greek roots meaning 'big' and 'sound'.